BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Business

  Alnylam To Webcast Conference Call Discussing Fourth Quarter And Full Year 2016 Financial Results

  February 2, 2017

   · 

  2 min read
• Somahlution Announces Multiple Site Initiation And Patient Enrollment In Spain For European DuraGraft Registry

  February 2, 2017

   · 

  2 min read
• Business

  Teva To Report Fourth Quarter 2016 Financial Results On February 13, 2017

  February 2, 2017

   · 

  1 min read
• Genetown

  Emulate Adds New Capabilities To “Human Emulation System” For Studying Viral Diseases

  February 2, 2017

   · 

  4 min read
• Teva Confirms Generic Victoza Patent Challenge In The United States

  February 2, 2017

   · 

  6 min read
• Business

  Merck & Co. Announces Fourth-Quarter And Full-Year 2016 Financial Results

  February 2, 2017

   · 

  1 min read
• FDA

  Sobi Obtains Approval From The European Commission (EC) For New Dosing Frequency Of Orfadin

  February 2, 2017

   · 

  3 min read
• Drug Development

  BioMarin Receives Access To Priority Medicines (PRIME) Regulatory Support From EMA For BMN 270 Gene Therapy In Hemophilia A

  February 2, 2017

   · 

  6 min read
• Drug Development

  Sobi - Long-Term Safety And Efficacy Data Of Extended Half-Life Therapy Alprolix In Children With Haemophilia B Published In The Lancet Haematology

  February 2, 2017

   · 

  9 min read
• Nanion Launches SURFE2R 96SE Instrument

  February 2, 2017

   · 

  2 min read